Utility of prognostic prediction by early assessment of response to combined treatment with nivolumab plus ipilimumab in patients with treatment-naïve metastatic renal cell carcinoma.

Subjects

Subjects :

Humans
Nivolumab therapeutic use
Ipilimumab therapeutic use
Prognosis
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carcinoma, Renal Cell diagnostic imaging
Carcinoma, Renal Cell drug therapy
Kidney Neoplasms diagnostic imaging
Kidney Neoplasms drug therapy
Kidney Neoplasms etiology

Details

Language :

English

ISSN :

1442-2042

Volume :

30

Issue :

9

Database :

MEDLINE

Journal :

International journal of urology : official journal of the Japanese Urological Association

Publication Type :

Academic Journal

Accession number :

36722291

Full Text :

https://doi.org/10.1111/iju.15144